BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26519601)

  • 41. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
    Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
    J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.
    Niu J; Azfer A; Rogers LM; Wang X; Kolattukudy PE
    Cardiovasc Res; 2007 Feb; 73(3):549-59. PubMed ID: 17207782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
    Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
    Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatoprotection by freshwater clam extract against CCl4-induced hepatic damage in rats.
    Hsu CL; Hsu CC; Yen GC
    Am J Chin Med; 2010; 38(5):881-94. PubMed ID: 20821820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-inflammatory and hepatoprotective effects of total flavonoid C-glycosides from Abrus mollis extracts.
    Chen M; Wang T; Jiang ZZ; Shan C; Wang H; Wu MJ; Zhang S; Zhang Y; Zhang LY
    Chin J Nat Med; 2014 Aug; 12(8):590-8. PubMed ID: 25156284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats.
    Pietrosi G; Fernández-Iglesias A; Pampalone M; Ortega-Ribera M; Lozano JJ; García-Calderó H; Abad-Jordà L; Conaldi PG; Parolini O; Vizzini G; Luca A; Bosch J; Gracia-Sancho J
    Liver Int; 2020 Oct; 40(10):2500-2514. PubMed ID: 32996708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biosynthesis of cerium oxide nanoparticles and their effect on lipopolysaccharide (LPS) induced sepsis mortality and associated hepatic dysfunction in male Sprague Dawley rats.
    Chen G; Xu Y
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():148-153. PubMed ID: 29208272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis.
    Delgado MG; Gracia-Sancho J; Marrone G; Rodríguez-Vilarrupla A; Deulofeu R; Abraldes JG; Bosch J; García-Pagán JC
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G496-502. PubMed ID: 23886859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
    Tugues S; Fernandez-Varo G; Muñoz-Luque J; Ros J; Arroyo V; Rodés J; Friedman SL; Carmeliet P; Jiménez W; Morales-Ruiz M
    Hepatology; 2007 Dec; 46(6):1919-26. PubMed ID: 17935226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma.
    Fernández-Varo G; Perramón M; Carvajal S; Oró D; Casals E; Boix L; Oller L; Macías-Muñoz L; Marfà S; Casals G; Morales-Ruiz M; Casado P; Cutillas PR; Bruix J; Navasa M; Fuster J; Garcia-Valdecasas JC; Pavel MC; Puntes V; Jiménez W
    Hepatology; 2020 Oct; 72(4):1267-1282. PubMed ID: 31961955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CeO
    Qin F; Shen T; Cao H; Qian J; Zou D; Ye M; Pei H
    Int J Nanomedicine; 2019; 14():4601-4611. PubMed ID: 31296989
    [No Abstract]   [Full Text] [Related]  

  • 55. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
    Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
    Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerium oxide nanoparticles: In pursuit of liver protection against doxorubicin-induced injury in rats.
    Ibrahim HG; Attia N; Hashem FEZA; El Heneidy MAR
    Biomed Pharmacother; 2018 Jul; 103():773-781. PubMed ID: 29684856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
    Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
    Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats.
    Chong LW; Hsu YC; Chiu YT; Yang KC; Huang YT
    J Biomed Sci; 2006 May; 13(3):403-18. PubMed ID: 16604421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.